Technology areas: Chemistry & Materials • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Abyrx Inc. has 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These matters are distributed across 2 distinct examiners and 2 distinct art units, meaning no two actions share the same examiner or administrative unit. PELLEGRINO, BRIAN E is the busiest examiner, with 1 pending action. This distribution of actions across different art units suggests the technology may span multiple sub-specialties within the medical device field.
For the practitioner, the presence of 2 distinct examiners and 2 distinct art units for only 2 pending actions indicates a decentralized prosecution environment. Each action must be handled independently, as there is no busiest examiner managing more than 1 pending action. This lack of concentration means that insights gained from one examiner may not be directly applicable to the other. The practitioner must be prepared to navigate different examiner preferences within the Medical Devices & Mechanical Engineering sector. With 2 distinct art units involved, the procedural expectations may also vary, requiring a flexible approach to the 2 pending office actions currently active.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PELLEGRINO, BRIAN E | 1 | 55.4% | +35.9% |
| PHILLIPS, SAVANNAH GRACE | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18294895 | NONABSORBABLE SETTABLE MULTI-PUTTY BONE CEMENTS, HEMOSTATIC COMPOSITIONS AND METHODS OF USE | PHILLIPS, SAVANNAH GRACE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18746364 | INTRAOPERATIVE USES OF SETTABLE SURGICAL COMPOSITIONS | PELLEGRINO, BRIAN E | — |
| Art Unit | Apps |
|---|---|
| 3799 | 1 |
| 1763 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18746364 | INTRAOPERATIVE USES OF SETTABLE SURGICAL COMPOSITIONS | PELLEGRINO, BRIAN E | 3799 | §103DP | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18294895 | NONABSORBABLE SETTABLE MULTI-PUTTY BONE CEMENTS, HEMOSTATIC COMPOSITIONS AND METHODS OF USE | PHILLIPS, SAVANNAH GRACE | 1763 | §103§112 | Non-Final OA | — | Pending | Feb 02, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAbyrx Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Brian E Pellegrino has the most, with 1 of Abyrx Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
